: Summary of 47 plasma metabolites consistently detected in a majority (> 75%) of samples with adequate precision (QCs with CV < 30%, n=25) in this step reduction intervention study by MSI-CE-MS. Figure S1 . Summary of changes in fasting plasma glucose and oral glucose tolerance (2hPG) responses in terms of (A) mM and (B) mg/dL following step reduction and recovery in a cohort of overweight and largely pre-diabetic participants. Overall, 7 (of 15 or 47%) participants were defined as pre-diabetic with impaired glucose tolerance (7.8-11 mM or 140-199 mg/dL 2hPG) with one subject also having impaired fasting glucose at baseline (BL). However, following the step reduction (SR) and/or the recovery (RC) period, most participants in this cohort were defined as pre-diabetic (12 out of 15 or 80%) with one participant becoming diabetic with impaired fasting glucose (> 7.0 mM or 126 mg/dL) and grossly elevated 2hPG (> 11.1 mM or 200 mg/dL) based on diagnostic criteria defined by Diabetes Canada. Overall, there were only two participants in this cohort (among 15 with blood glucose measurements) who maintained normal glucose homeostasis and glucose tolerance throughout the intervention period. Figure S2 . Individual metabolic trajectories for the top-ranked 8 plasma metabolites associated with physical inactivity from a cohort of overweight/pre-diabetic older adults at baseline (BL), following 2 weeks of step reduction (SR) and after resuming normal habitual activity upon recovery for two weeks (RC). Despite collection of blood specimens under standardized conditions with fasting/morning plasma samples collected after participants were provided 2 days of standardized meals, there was considerable between-subject variability in circulating plasma metabolite concentrations, including their dynamic responses to step reduction. Figure S3 . Ratiometric plasma markers associated with physical inactivity from a cohort of overweight/pre-diabetic older adults at baseline (BL), following 2 weeks of step reduction (SR) and after resuming normal habitual activity upon recovery for two weeks (RC). All ratiometric biomarker satisfied Benjamini-Hochberg adjustment (q < 0.05, FDR) for multiple hypothesis testing, which increased the effect size as compared to most single plasma metabolites (e.g., creatine, oxo-proline, indoxyl sulfate) with the exception of glutamine and carnitine. Overall, most ratiometric markers reflected significant changes in circulating metabolites associated with muscle tissue energy metabolism and oxidative stress upon step reduction with a persistent perturbation from baseline even after two weeks of recovery with normal habitual activity. 
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